8-KLeadership ChangesCorporate ChangesExhibits & Filings

Merck & Co., Inc. 8-K Report, Executive Changes (Jun 28, 2005)

Filed June 28, 2005For Securities:MRK

Summary

This 8-K filing from Schering-Plough Corporation, dated June 28, 2005, primarily announces two key corporate governance changes. Firstly, the company appointed Thomas J. Colligan to its Board of Directors, effective June 27, 2005, and also placed him on the Audit and Finance Committees. This signals a potential strengthening of the board's oversight capabilities in financial matters. Secondly, Schering-Plough adopted Amended and Restated By-laws, effective June 28, 2005. These amendments aim to enhance clarity, modernize provisions, and introduce greater flexibility in corporate operations. Notable changes include allowing the Board to set annual shareholder meeting dates, enabling email notification for special board meetings, reducing committee membership requirements, and eliminating the Vice Chairman and President officer positions while clarifying officer removal procedures.

Key Highlights

  • 1Appointment of Thomas J. Colligan to the Board of Directors and its Audit and Finance Committees.
  • 2Adoption of Amended and Restated By-laws by the Board of Directors.
  • 3By-laws amendments grant the Board flexibility in setting the annual shareholder meeting date.
  • 4By-laws now permit electronic notification for special Board of Directors meetings.
  • 5Reduction in minimum committee membership from three to one member.
  • 6Elimination of the Vice Chairman and President officer titles.
  • 7Clarification of the Board's authority to remove officers with or without cause.

Frequently Asked Questions